Newmedical Technology, Inc.
Martin Floreani is a seasoned executive with extensive experience in commercial leadership and strategic management across various industries, including healthcare and consumer goods. Currently serving as Chief Commercial Officer at Newmedical Technology, Inc., Martin oversees the global success of prominent brands in scar and bruise management. Previous roles include Senior Executive Consultant at Bayshore Dental Studio, where responsibilities encompassed marketing and business development, and CEO of Dentovations Inc., responsible for launching multiple brands during the pandemic. Martin has also held significant positions at French Transit, LLC, Enaltus, Advanced Bio-Technologies, and Stiefel Laboratories, demonstrating a strong track record in P&L management, strategic planning, and market development. An MBA graduate from the University of Miami, Martin possesses in-depth expertise in finance and marketing, further solidified by valuable roles at Merck and Kao Corporation.
This person is not in any teams
This person is not in any offices
Newmedical Technology, Inc.
Newmedical Technology, Inc. is a manufacturer and global leader in aesthetic scar management, bruise recovery, and advanced wound care. Since 2003, our products have been delivering quality and innovation in post-surgical recovery and care. NEWGEL™ and SILAGEN® products are among the fastest growing, most awarded, and widely recommended scar therapy brands among physicians. Both brands offer medical-grade silicone gel and sheeting in the management and prevention of all types of scars. BruiseMD® is among the most effective choices for surgical and non-surgical post-procedure recovery. Devrasorb® offers innovative foam dressings that provide superior absorption and retention for wound cleansing; designed to respond, encourage, and help accelerate healing with a varying wound environment. Our products are available in over 30 countries and manufactured exclusively in our ISO 13485 FDA registered facility in Northbrook, Illinois.